{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:44:26Z","timestamp":1791945866607,"version":"4.3.4"},"reference-count":130,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.molmed.2020.07.002","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T17:01:53Z","timestamp":1598634113000},"page":"953-968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Meet Your Stress Management Professionals: The Endocannabinoids"],"prefix":"10.1016","volume":"26","author":[{"given":"Terri A.","family":"deRoon-Cassini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Stollenwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Beatka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia J.","family":"Hillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2020.07.002_bb0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yhbeh.2008.12.009","article-title":"The Reactive Scope Model - a new model integrating homeostasis, allostasis, and stress","volume":"55","author":"Romero","year":"2009","journal-title":"Horm. Behav."},{"key":"10.1016\/j.molmed.2020.07.002_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2019.19010091","article-title":"Translating developmental neuroscience to understand risk for psychiatric disorders","volume":"176","author":"Meyer","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1037\/hea0000567","article-title":"Affective reactivity to daily stress and 20-year mortality risk in adults with chronic illness: findings from the National Study of Daily Experiences","volume":"37","author":"Chiang","year":"2018","journal-title":"Health Psychol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0020","author":"Ritchie"},{"key":"10.1016\/j.molmed.2020.07.002_bb0025","article-title":"Neurobiological and systemic effects of chronic stress","volume":"1","author":"McEwen","year":"2017","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"10.1016\/j.molmed.2020.07.002_bb0030","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molmed.2020.07.002_bb0035","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1021\/acschemneuro.7b00508","article-title":"Functional relevance of endocannabinoid-dependent synaptic plasticity in the central nervous system","volume":"9","author":"Augustin","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2015.10.001","article-title":"The endocannabinoid signaling system in the CNS: a primer","volume":"125","author":"Hillard","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0045","doi-asserted-by":"crossref","first-page":"35829","DOI":"10.1038\/srep35829","article-title":"Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.07.002_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.molmed.2020.07.002_bb0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1073\/pnas.1910322116","article-title":"Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala","volume":"117","author":"Yasmin","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.07.002_bb0060","doi-asserted-by":"crossref","first-page":"100158","DOI":"10.1016\/j.ynstr.2019.100158","article-title":"Cell signaling dependence of rapid glucocorticoid-induced endocannabinoid synthesis in hypothalamic neuroendocrine cells","volume":"10","author":"Harris","year":"2019","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.molmed.2020.07.002_bb0065","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/EC-17-0111","article-title":"Endocrinology and the brain: corticotropin-releasing hormone signaling","volume":"6","author":"Inda","year":"2017","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.molmed.2020.07.002_bb0070","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1523\/JNEUROSCI.2737-14.2015","article-title":"Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety","volume":"35","author":"Gray","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0075","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1523\/JNEUROSCI.3445-12.2014","article-title":"Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice","volume":"34","author":"Morgan","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0080","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain","volume":"16","author":"Sim","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0085","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0090","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/npp.2010.44","article-title":"FAAH-\/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration","volume":"35","author":"Falenski","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neubiorev.2015.07.001","article-title":"Stress habituation, body shape and cardiovascular mortality","volume":"56","author":"Peters","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.molmed.2020.07.002_bb0100","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1111\/j.1460-9568.2008.06266.x","article-title":"Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation","volume":"27","author":"Patel","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0105","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0914661107","article-title":"Endogenous cannabinoid signaling is essential for stress adaptation","volume":"107","author":"Hill","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.07.002_bb0110","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/npp.2009.101","article-title":"Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala","volume":"34","author":"Patel","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0115","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/s41386-018-0135-4","article-title":"Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity","volume":"43","author":"Segev","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0120","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.euroneuro.2018.02.004","article-title":"Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD","volume":"28","author":"Fidelman","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0125","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/mp.2012.90","article-title":"Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure","volume":"18","author":"Hill","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/mol.110.064196","article-title":"Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition","volume":"78","author":"Rossi","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0135","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/npp.2014.198","article-title":"Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain","volume":"40","author":"Lomazzo","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.15000","article-title":"Termination of acute stress response by the endocannabinoid system is regulated through lysine-specific demethylase 1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL","author":"Longaretti","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2020.07.002_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2016.10.008","article-title":"Chronic stress leads to epigenetic dysregulation in the neuropeptide-Y and cannabinoid CB1 receptor genes in the mouse cingulate cortex","volume":"113","author":"Lomazzo","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bcp.2018.08.012","article-title":"Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders","volume":"157","author":"Mato","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2018.11.036","article-title":"Early life stress alters the developmental trajectory of corticolimbic endocannabinoid signaling in male rats","volume":"146","author":"Hill","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.euroneuro.2018.02.003","article-title":"Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex","volume":"28","author":"Portero-Tresserra","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ibror.2018.05.002","article-title":"Effects of an early life experience on rat brain cannabinoid receptors in adolescence and adulthood","volume":"5","author":"Vangopoulou","year":"2018","journal-title":"IBRO Rep."},{"key":"10.1016\/j.molmed.2020.07.002_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.psyneuen.2018.02.021","article-title":"Glucocorticoid-endocannabinoid uncoupling mediates fear suppression deficits after early-life stress","volume":"91","author":"Atsak","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0180","doi-asserted-by":"crossref","first-page":"e0","DOI":"10.1038\/tp.2017.38","article-title":"Utilization of machine learning for prediction of post-traumatic stress: a re-examination of cortisol in the prediction and pathways to non-remitting PTSD","volume":"7","author":"Galatzer-Levy","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2017.tb00740.x","article-title":"Endocannabinoid signaling and the hypothalamic-pituitary-adrenal axis","volume":"7","author":"Hillard","year":"2016","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0190","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/JME-17-0019","article-title":"Epigenetic programming of the neuroendocrine stress response by adult life stress","volume":"59","author":"Dirven","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00210-004-1003-9","article-title":"Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system","volume":"371","author":"Pfitzer","year":"2005","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0200","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.bjp.0704359","article-title":"Effects of cannabinoids on adrenaline release from adrenal medullary cells","volume":"134","author":"Niederhoffer","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0205","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/37371","article-title":"Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock","volume":"390","author":"Wagner","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.07.002_bb0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1124\/jpet.109.163998","article-title":"Anti-inflammatory properties of CB1-receptor antagonist involves beta2 adrenoceptors","volume":"333","author":"Mnich","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.molmed.2020.07.002_bb0215","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1073\/pnas.1218573110","article-title":"Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB(1) receptor blockade","volume":"110","author":"Bellocchio","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.07.002_bb0220","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1073\/pnas.1525066113","article-title":"Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation","volume":"113","author":"Busquets-Garcia","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.07.002_bb0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/npp.2017.130","article-title":"Circulating endocannabinoids: from whence do they come and where are they going?","volume":"43","author":"Hillard","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0235","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41401-018-0051-5","article-title":"Integrating endocannabinoid signaling in the regulation of anxiety and depression","volume":"40","author":"Yin","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.molmed.2020.07.002_bb0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00213-018-5127-x","article-title":"Tempering aversive\/traumatic memories with cannabinoids: a review of evidence from animal and human studies","volume":"236","author":"Lisboa","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0245","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.neuron.2019.12.024","article-title":"Endocannabinoid signaling collapse mediates stress-induced amygdalo-cortical strengthening","volume":"105","author":"Marcus","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2020.07.002_bb0250","article-title":"Cannabinoids as therapeutics for PTSD","volume":"107551","author":"Sbarski","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2020.07.002_bb0255","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euroneuro.2018.05.008","article-title":"Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function","volume":"28","author":"Sbarski","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0260","doi-asserted-by":"crossref","first-page":"100176","DOI":"10.1016\/j.ynstr.2019.100176","article-title":"Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system","volume":"11","author":"Wyrofsky","year":"2019","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.molmed.2020.07.002_bb0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2017.03.010","article-title":"Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion","volume":"292","author":"Reyes","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0270","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0275","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1523\/JNEUROSCI.2251-18.2018","article-title":"Upregulation of anandamide hydrolysis in the basolateral complex of amygdala reduces fear memory expression and indices of stress and anxiety","volume":"39","author":"Morena","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0280","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/FBP.0000000000000426","article-title":"The acute effects of cannabis on human executive function","volume":"29","author":"Oomen","year":"2018","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0285","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.2174\/13816128113196660735","article-title":"Endocannabinoid signaling in the etiology and treatment of major depressive illness","volume":"20","author":"Hillard","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.molmed.2020.07.002_bb0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-pharmtox-010716-104615","article-title":"Don't worry, be happy: endocannabinoids and cannabis at the intersection of stress and reward","volume":"57","author":"Volkow","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0295","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41591-018-0299-9","article-title":"Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior","volume":"25","author":"Shen","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2020.07.002_bb0300","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/npp.2015.142","article-title":"Stress-induced reinstatement of drug seeking: 20 years of progress","volume":"41","author":"Mantsch","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2017.09.024","article-title":"Stress promotes drug seeking through glucocorticoid-dependent endocannabinoid mobilization in the prelimbic cortex","volume":"84","author":"McReynolds","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0310","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1073\/pnas.0900835106","article-title":"Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory","volume":"106","author":"Campolongo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.07.002_bb0315","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1038\/npp.2011.166","article-title":"Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation","volume":"36","author":"Sumislawski","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0320","doi-asserted-by":"crossref","first-page":"18333","DOI":"10.1073\/pnas.1420285111","article-title":"Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training","volume":"111","author":"Morena","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.07.002_bb0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.psyneuen.2019.06.018","article-title":"Anandamide modulation of circadian- and stress-dependent effects on rat short-term memory","volume":"108","author":"Santori","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0330","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.phrs.2016.07.024","article-title":"The endocannabinoid system and post traumatic stress disorder (PTSD): from preclinical findings to innovative therapeutic approaches in clinical settings","volume":"111","author":"Berardi","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molmed.2020.07.002_bb0335","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fnins.2018.00479","article-title":"Inhibition of diacylglycerol lipase impairs fear extinction in mice","volume":"12","author":"Cavener","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0340","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/mp.2012.72","article-title":"Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity","volume":"18","author":"Gunduz-Cinar","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0345","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/npp.2013.191","article-title":"Learning not to fear: neural correlates of learned safety","volume":"39","author":"Kong","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0350","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jpsychires.2017.02.002","article-title":"Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus","volume":"90","author":"Micale","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.molmed.2020.07.002_bb0355","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1476-5381.2011.01352.x","article-title":"The case for peripheral CB(1) receptor blockade in the treatment of visceral obesity and its cardiometabolic complications","volume":"163","author":"Kunos","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0360","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2710.2010.01164.x","article-title":"An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity","volume":"36","author":"Christopoulou","year":"2011","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.molmed.2020.07.002_bb0365","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-009-1517-4","article-title":"Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers","volume":"205","author":"Horder","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0370","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1017\/S1461145710000453","article-title":"Reduced neural response to reward following 7 days treatment with the cannabinoid CB(1) antagonist rimonabant in healthy volunteers","volume":"13","author":"Horder","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0375","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-5380-3-19","article-title":"Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses","volume":"3","author":"Hill","year":"2013","journal-title":"Biol. Mood Anxiety Disord."},{"key":"10.1016\/j.molmed.2020.07.002_bb0380","doi-asserted-by":"crossref","first-page":"e905","DOI":"10.1038\/tp.2016.169","article-title":"Endocannabinoid signaling in social functioning: an RDoC perspective","volume":"6","author":"Karhson","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0385","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pnpbp.2017.04.004","article-title":"Prefrontal endocannabinoids, stress controllability and resilience: a hypothesis","volume":"85","author":"Worley","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0390","first-page":"1177","article-title":"An endocannabinoid receptor polymorphism modulates affective processing under stress","volume":"13","author":"Wirz","year":"2018","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0395","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41401-018-0081-z","article-title":"Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies","volume":"40","author":"Sloan","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.molmed.2020.07.002_bb0400","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1038\/npp.2014.110","article-title":"Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors","volume":"39","author":"Pietrzak","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0405","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.biopsych.2015.12.021","article-title":"Interactions between anandamide and corticotropin-releasing factor signaling modulate human amygdala function and risk for anxiety disorders: an imaging genetics strategy for modeling molecular interactions","volume":"80","author":"Demers","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0410","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/09658211.2017.1347685","article-title":"A variant on promoter of the cannabinoid receptor 1 gene (CNR1) moderates the effect of valence on working memory","volume":"26","author":"Fairfield","year":"2018","journal-title":"Memory"},{"key":"10.1016\/j.molmed.2020.07.002_bb0415","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/gbb.12352","article-title":"Variants in the CNR1 gene predispose to headache with nausea in the presence of life stress","volume":"16","author":"Juhasz","year":"2017","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.molmed.2020.07.002_bb0420","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1037\/abn0000079","article-title":"Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: evidence from an endocannabinoid system-level analysis","volume":"124","author":"Carey","year":"2015","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0425","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fncel.2019.00138","article-title":"Effects of different stressors are modulated by different neurobiological systems: the role of GABA-A Versus CB1 receptor gene variants in anxiety and depression","volume":"13","author":"Gonda","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0430","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/ncomms7395","article-title":"FAAH genetic variation enhances fronto-amygdala function in mouse and human","volume":"6","author":"Dincheva","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.07.002_bb0435","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/acer.13210","article-title":"FAAH gene variation moderates stress response and symptom severity in patients with posttraumatic stress disorder and comorbid alcohol dependence","volume":"40","author":"Spagnolo","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.molmed.2020.07.002_bb0440","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41380-018-0215-1","article-title":"Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice","volume":"25","author":"Mayo","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0445","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.euroneuro.2016.03.003","article-title":"Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma","volume":"26","author":"Lazary","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0450","doi-asserted-by":"crossref","first-page":"100154","DOI":"10.1016\/j.ynstr.2019.100154","article-title":"FAAH genotype, CRFR1 genotype, and cortisol interact to predict anxiety in an aging, rural Hispanic population: a Project FRONTIER study","volume":"10","author":"Harris","year":"2019","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.molmed.2020.07.002_bb0455","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2019.07.034","article-title":"Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: a randomized, controlled experimental medicine trial","volume":"87","author":"Mayo","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0460","doi-asserted-by":"crossref","first-page":"172738","DOI":"10.1016\/j.pbb.2019.172738","article-title":"Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling","volume":"184","author":"Xue","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.molmed.2020.07.002_bb0465","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2007.04688.x","article-title":"Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity","volume":"103","author":"Hill","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2020.07.002_bb0470","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/npp.2016.3","article-title":"Ketamine and MAG lipase inhibitor-dependent reversal of evolving depressive-like behavior during forced abstinence from alcohol drinking","volume":"41","author":"Holleran","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0475","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/npp.2016.194","article-title":"Pathogen-host defense in the evolution of depression: insights into epidemiology, genetics, bioregional differences and female preponderance","volume":"42","author":"Raison","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0480","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0485","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20050","article-title":"Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study","volume":"53","author":"Nunez","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.molmed.2020.07.002_bb0490","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hipo.22558","article-title":"Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus","volume":"26","author":"Li","year":"2016","journal-title":"Hippocampus"},{"key":"10.1016\/j.molmed.2020.07.002_bb0495","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jamapsychiatry.2019.2508","article-title":"Association of genetic liability to psychotic experiences with neuropsychotic disorders and traits","volume":"76","author":"Legge","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0500","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017403","article-title":"The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: a meta-analysis","volume":"98","author":"Kong","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.molmed.2020.07.002_bb0505","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/10615806.2020.1732358","article-title":"Association of cannabinoid receptor genes (CNR1 and CNR2) polymorphisms and panic disorder","volume":"33","author":"Peiro","year":"2020","journal-title":"Anxiety Stress Coping"},{"key":"10.1016\/j.molmed.2020.07.002_bb0510","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jad.2019.07.083","article-title":"A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes","volume":"257","author":"Lazary","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.molmed.2020.07.002_bb0515","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1460-9568.2004.03428.x","article-title":"Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala","volume":"20","author":"Gulyas","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0520","doi-asserted-by":"crossref","first-page":"24845","DOI":"10.1074\/jbc.M114.557025","article-title":"Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons","volume":"289","author":"Laprairie","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.07.002_bb0525","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2019.00350","article-title":"Cannabinoid CB1 and CB2 receptor-mediated arrestin translocation: species, subtype, and agonist-dependence","volume":"10","author":"Ibsen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0530","doi-asserted-by":"crossref","first-page":"112495","DOI":"10.1016\/j.psychres.2019.112495","article-title":"Endogenous cannabinoid levels and suicidality in combat veterans","volume":"287","author":"Sher","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.molmed.2020.07.002_bb0535","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.physbeh.2018.12.018","article-title":"Weight loss and improved mood after aerobic exercise training are linked to lower plasma anandamide in healthy people","volume":"201","author":"Belitardo de Oliveira","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.molmed.2020.07.002_bb0540","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jts.22253","article-title":"Psychobiological responses to aerobic exercise in individuals with posttraumatic stress disorder","volume":"31","author":"Crombie","year":"2018","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.molmed.2020.07.002_bb0545","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1249\/MSS.0000000000002006","article-title":"Serum endocannabinoid and mood changes after exercise in major depressive disorder","volume":"51","author":"Meyer","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.molmed.2020.07.002_bb0550","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-clinpsy-050718-095432","article-title":"Man and the microbiome: a new theory of everything?","volume":"15","author":"Butler","year":"2019","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0555","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0560","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2014-3455","article-title":"Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol","volume":"100","author":"Hanlon","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2020.07.002_bb0565","doi-asserted-by":"crossref","first-page":"104471","DOI":"10.1016\/j.psyneuen.2019.104471","article-title":"Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)","volume":"111","author":"Hanlon","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0570","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.molmed.2020.07.002_bb0575","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2146\/ajhp140523","article-title":"Use and effects of cannabinoids in military veterans with posttraumatic stress disorder","volume":"72","author":"Betthauser","year":"2015","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.molmed.2020.07.002_bb0580","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00213-020-05499-8","article-title":"Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study","volume":"237","author":"Rabinak","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0585","first-page":"e102","article-title":"Medical cannabis in patients with chronic pain: effect on pain relief, pain disability, and psychological aspects. a prospective non randomized single arm clinical trial","volume":"169","author":"Poli","year":"2018","journal-title":"Clin. Ter."},{"key":"10.1016\/j.molmed.2020.07.002_bb0590","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2020.07.002_bb0595","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/da.22596","article-title":"Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: a literature review","volume":"34","author":"Steenkamp","year":"2017","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.molmed.2020.07.002_bb0600","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/medicina55090525","article-title":"Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review","volume":"55","author":"Orsolini","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.molmed.2020.07.002_bb0605","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety","volume":"21","author":"Fabre","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0610","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.molmed.2020.07.002_bb0615","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00406-018-0970-7","article-title":"Cannabis and mental illness: a review","volume":"269","author":"Lowe","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.002_bb0620","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.molmed.2020.07.002_bb0625","first-page":"60","article-title":"Rapid changes in cannabinoid 1 receptor availability in cannabis-dependent male subjects after abstinence from cannabis","volume":"1","author":"D'Souza","year":"2016","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.molmed.2020.07.002_bb0630","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2016.04.012","article-title":"Fatty acid amide hydrolase binding in brain of cannabis users: imaging with the novel radiotracer [(11)C]CURB","volume":"80","author":"Boileau","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2020.07.002_bb0635","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pbb.2019.03.006","article-title":"Cannabinoids, interoception, and anxiety","volume":"180","author":"Andrade","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.molmed.2020.07.002_bb0640","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11920-019-1026-z","article-title":"Cannabinoid regulation of fear and anxiety: an update","volume":"21","author":"Papagianni","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.molmed.2020.07.002_bb0645","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm J."},{"key":"10.1016\/j.molmed.2020.07.002_bb0650","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s40265-018-0992-5","article-title":"Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis","volume":"78","author":"Lattanzi","year":"2018","journal-title":"Drugs"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420301775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420301775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:21:03Z","timestamp":1761463263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491420301775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":130,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1471491420301775"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2020.07.002","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meet Your Stress Management Professionals: The Endocannabinoids","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2020.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}